OncoSec Medical to Present at NYSSA Life Sciences and LD Micro Investor Conferences

SAN DIEGO – November 27, 2012 — OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers, announced that the company will provide an overview of its technologies, development programs, and outlook at the following investor conferences in upcoming weeks:

 New York Society of Security Analysts (NYSSA) Life Sciences Conference, NYSSA Conference Center, 1540 Broadway, New York, NY, November 29th at 9:30 AM ET

Presentation by: Veronica Vallejo, CPA, Vice President of Finance

LD Micro Conference, Luxe Sunset Bel Air Hotel, 11461 Sunset Boulevard, Los Angeles, CA, December 5th at 11:00 AM PT

Presentation by: Punit Dhillon, President & CEO